Serum levels of infliximab and adalimumab are associated with deep remission in inflammatory bowel disease Óscar Pascual-Marmaneu, María D. Belles-Medall, Raúl Ferrando-Piqueres, Pedro Almela-Notari, María Mendoza-Aguilera, Tamara Álvarez-Martín

Effectiveness and safety of adalimumab biosimilar in patients with inflammatory bowel disease Jaime E. Poquet-Jornet, Ibanez-Sala, Teresa Garrigues-Pelufo, Adrián Munilla-Das, Valdivia-Perez, Francisco Javier Carrera-Hueso

Adherence to biological therapies in patients with chronic inflammatory arthropathies Noemí Martínez-López de Castro, Miriam Álvarez-Payero, Marisol Samartín-Ucha, Alicia Martín-Vila, Guadalupe Piñeiro-Corrales, José María Pego Reigosa